1. Home
  2. TNET vs PGEN Comparison

TNET vs PGEN Comparison

Compare TNET & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriNet Group Inc.

TNET

TriNet Group Inc.

HOLD

Current Price

$66.86

Market Cap

3.0B

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.18

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNET
PGEN
Founded
1988
1998
Country
United States
United States
Employees
2700
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.8B
IPO Year
2000
2013

Fundamental Metrics

Financial Performance
Metric
TNET
PGEN
Price
$66.86
$4.18
Analyst Decision
Hold
Buy
Analyst Count
7
4
Target Price
★ $66.20
$13.65
AVG Volume (30 Days)
352.7K
★ 5.5M
Earning Date
10-29-2026
11-04-2026
Dividend Yield
★ 1.74%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 3.70
0.12
Revenue
★ $5,010,000,000.00
$230,981,000.00
Revenue This Year
N/A
$2,335.22
Revenue Next Year
$4.82
$85.34
P/E Ratio
★ $18.05
$168.50
Revenue Growth
N/A
★ N/A
52 Week Low
$33.67
$3.04
52 Week High
$76.59
$8.98

Technical Indicators

Market Signals
Indicator
TNET
PGEN
Relative Strength Index (RSI) 47.80 32.63
Support Level $63.83 $5.01
Resistance Level $71.56 $5.47
Average True Range (ATR) 3.57 0.46
MACD -0.74 -0.16
Stochastic Oscillator 41.48 13.23

Price Performance

Historical Comparison
TNET
PGEN

About TNET TriNet Group Inc.

Trinet Group Inc provides human resources solutions for small and medium-sized businesses through technology-enabled services. Its offerings include human capital expertise, employee benefits such as health insurance and retirement plans, payroll and payroll tax administration, risk mitigation, and compliance consulting. The company provides its services through professional employer organization (PEO) services delivered via a co-employment model, as well as administrative services organization (ASO) offerings. The majority of the company's revenue is derived from the insurance-related billings and administrative fees collected from PEO clients.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: